Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

J Chalmers, N Poulter… - Diabetes, Obesity and …, 2012 - Wiley Online Library
Aims: To determine the baseline characteristics and glucose‐lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …
被引用次数：52 相关文章

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial.

S van Dieren, S Czernichow… - Diabetes, Obesity & …, 2012 - search.ebscohost.com
Aims: To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

S van Dieren, S Czernichow… - Diabetes, Obesity …, 2012 - researchnow.flinders.edu.au
Aims: To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial.

S van Dieren, S Czernichow, J Chalmers… - Diabetes, Obesity & …, 2012 - europepmc.org
Aims To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods Eleven thousand one …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

S van Dieren, S Czernichow, J Chalmers… - Diabetes, Obesity and …, 2012 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Aims:</jats: bold> To determine the baseline characteristics and
glucose‐lowering therapies associated with weight change among patients with type 2 …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

S van Dieren, S Czernichow, J Chalmers, AP Kengne… - 2012 - pubmed.ncbi.nlm.nih.gov
Aims To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods Eleven thousand one …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

S van Dieren, S Czernichow… - Diabetes, Obesity …, 2012 - research.monash.edu
Aims: To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …

[引用][C] Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial.

S Dieren, S Czernichow, J Chalmers, AP Kengne… - 2012 - repository.ubn.ru.nl
AIMS: To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. METHODS: Eleven thousand one …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

S van Dieren, S Czernichow… - Diabetes, Obesity …, 2012 - pure.johnshopkins.edu
Aims: To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …

Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial

S van Dieren, S Czernichow… - Diabetes …, 2012 - researchinformation.amsterdamumc …
Aims: To determine the baseline characteristics and glucose-lowering therapies associated
with weight change among patients with type 2 diabetes. Methods: Eleven thousand one …